Abstract Objective To explore the effect of family pharmacist service model on patients with stable chronic obstructive pulmonary disease (COPD). Methods A total of 80 COPD patients with grade B and C of global initiative for COPD were selected from Jiaxing Traditional Chinese Medicine Hospital, Zhejiang Province from April 2019 to March 2020, and they were divided into observation group and control group according to random number table method, with 40 patients in each group. The observation group received the family pharmacist service, and the control group received routine medical treatment. Both groups were followed up for one year. The scores of medication compliance, St. George’s respiratory questionnaire (SGRQ), COPD assessment test (CAT) before and after intervention were compared between the two groups, and the differences in acute exacerbations between the two groups were compared. Results In the observation group, four cases were lost to follow-up, and 36 cases were finally included. In the control group, two cases were lost to follow-up, and 38 cases were finally included. After intervention, the medication compliance scores of both groups were higher than those before intervention, and those of observation group were higher than those of control group, the differences were statistically significant (P＜0.05). After intervention, the scores of SGRQ, CAT, and acute exacerbations in two groups were lower than those before intervention, and those of observation group were lower than those of control group, the differences were statistically significant (P＜0.05). Conclusion The family pharmacist service model can effectively improve the medication compliance of patients with stable COPD, promote the rational and standardized drug use of patients, and the clinical application of value.
XU Hui RUAN Weifeng▲ MA Tianhong LI Liang FAN Xiaoliang. Effect of family pharmacist service model on patients with stable chronic obstructive pulmonary disease[J]. 中国医药导报, 2023, 20(25): 94-98.
